Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for pediatric Bell's palsy
ACTRN12615000563561Phase 3Recruiting
- Sponsor
- Franz Babl
- Start
- Oct 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Bell's palsy comparing Prednisolone with Placebo (2 arms). Primary endpoint: Complete recovery at 1 month by House-Brackmann score. Started Oct 2015; status: recruiting.
02
Drugs
prednisolone
03
Conditions
Bell's palsy
Beyond the preview
Go deeper on ACTRN12615000563561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000563561.